These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3784966)

  • 41. [The combination of repeated anesthetic "bathing" of the cervico-thoracic system and buflomedil in analgesic therapy of in Raynaud's syndrome of the arm].
    Bonezzi C; Navazio Cassa G; Sangiovanni G; Brambilla GL
    Minerva Cardioangiol; 1985 Oct; 33(10):655-7. PubMed ID: 4080170
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L; Gandolfo AM; Utz C
    MMW Munch Med Wochenschr; 1984 Mar; 126(9):247-8. PubMed ID: 6425678
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibitory effect of buflomedil on prostate alpha1A adrenoceptor in the Wistar rat.
    Tang LM; Cheng JT; Tong YC
    Neurosci Lett; 2004 Sep; 367(2):224-7. PubMed ID: 15331158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V; Mammarella A; Alessandrini A; Barlattani M
    Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
    Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Morphometric analysis of erythrocyte aggregates in vitro: pharmacological application with buflomedil].
    Carpentier PH; Imbert B; Picart C; Brasseur S; Malterre C
    J Mal Vasc; 2000 Dec; 25(5):356-359. PubMed ID: 11148398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fatal poisoning caused by buflomedil].
    Tomassini E; Poussel JF; Guiot P
    Ann Fr Anesth Reanim; 1999 Dec; 18(10):1091-2. PubMed ID: 10652948
    [No Abstract]   [Full Text] [Related]  

  • 49. Buflomedil poisoning: a potentially life-threatening intoxication.
    Vandemergel X; Biston P; Lenearts L; Marécaux G; Daune M
    Intensive Care Med; 2000 Nov; 26(11):1713. PubMed ID: 11193288
    [No Abstract]   [Full Text] [Related]  

  • 50. [Fatal suicide by buflomedil poisoning].
    Cochard G; Tanguy L; Dubois A; Sizun J
    Presse Med; 1991 Nov; 20(35):1739-40. PubMed ID: 1836592
    [No Abstract]   [Full Text] [Related]  

  • 51. Acute buflomedil intoxication: a critically life-threatening condition.
    Gueugniaud PY; Roux H; Petit P
    Intensive Care Med; 1995 May; 21(5):463-4. PubMed ID: 7665760
    [No Abstract]   [Full Text] [Related]  

  • 52. Gas chromatographic evaluation of buflomedil in biological samples employing the thermoionic specific detector.
    Marzo A; Lucarelli C
    J Chromatogr; 1988 Jun; 427(2):345-50. PubMed ID: 3410916
    [No Abstract]   [Full Text] [Related]  

  • 53. [Does conjunctival biomicroscopy enable one to assess the microcirculatory activity of buflomedil?].
    Maurel A; Balanger S; Lagrue G
    J Mal Vasc; 1985; 10 Suppl A():176-7. PubMed ID: 4031673
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pioneer experience with buflomedil in the form of retrograde venous pulse therapy for treatment of ischemia and severe extremity infections].
    Cavini-Ferreira PC
    Wien Med Wochenschr; 1993; 143(7-8):193-4. PubMed ID: 8379175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Phosphodiesterase inhibition as the action mechanism of various coronary vasodilator agents].
    Kukovetz WR; Pöch G; Holzmann S
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):730. PubMed ID: 4341664
    [No Abstract]   [Full Text] [Related]  

  • 56. [Buflomedil: new findings on its mechanism of action].
    Med Monatsschr Pharm; 1986 Oct; 9(10):311-2. PubMed ID: 3784966
    [No Abstract]   [Full Text] [Related]  

  • 57. Tissular oxygenation and venoarteriolar reflex disturbances in diabetes mellitus: vasoregulator effect of Buflomedil.
    Le Devehat C; Khodabandehlou T; Vimeux M
    Clin Hemorheol Microcirc; 1999; 21(3-4):329-34. PubMed ID: 10711765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Decrease of blood viscosity induced by buflomedil in healthy volunteers].
    Craveri A; Tornaghi G; Paganardi L; Ranieri R; Di Bella M
    Minerva Cardioangiol; 1988; 36(7-8):357-60. PubMed ID: 3211334
    [No Abstract]   [Full Text] [Related]  

  • 59. [Platelet function after the single administration of buflomedil].
    Sinzinger H; Wirthumer-Hoche C
    Wien Klin Wochenschr; 1985 Sep; 97(18):720-2. PubMed ID: 4072227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Protective effect of buflomedil hydrochloride on erythrocyte sickling. In vitro study].
    Briguglio F; Briguglio E; Di Marco V
    Minerva Med; 1986 Feb; 77(7-8):249-62. PubMed ID: 3951731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.